A0A4Y5UGE4 (A0A4Y5UGE4_HUMAN) Homo sapiens (Human)

T-cell surface glycoprotein CD4 UniProtKBInterProInteractive Modelling

458 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P01730

Available Structures

77 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4
3t0e
 Heteromer
A0A5B9; P01730; P01848; P01903; P01911; 		26-388
Assess
cryoEM reconstruction of the HIV gp140 in complex with the extracellular domains of CD4 and the adn…
7t0o
 Heteromer
P01730; Q2N0S6; 		26-388
Assess
Structural basis of coreceptor recognition by HIV-1 envelope spike
6met
 Heteromer
P01730; P51681; Q70145; 		26-388
6×NAG; 2×NAG; 1×NAG; 7×NAG; 1×A2G;
Assess
Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with C…
5u1f
 Heteromer
P01730; Q2N0S6; 		26-388
Assess
Crystal structure of the anti-CD4 adnectin 6940_B01 as a complex with the extracellular domains of …
7t0r
 Heteromer
P01730; 		26-386
1×NAG; 1×SO4;
Assess
Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformati…
3jwd
 Heteromer
P01730; 		26-208
10×NAG;
Assess
Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformati…
3jwo
 Heteromer
P01730; 		26-208
1×NAG; 10×NAG;
Assess
Crystal structure of murine 2D5 Fab, a potent anti-CD4 HIV-1-neutralizing antibody in complex with …
4q6i
 Heteromer
P01730; 		26-207
Assess
HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibo…
2ny1
 Heteromer
P01730; Q6N030; Q6P5S8; Q993A8; 		26-206
1×GLC; 14×NAG;
Assess
HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibo…
2ny2
 Heteromer
P01730; P19551; Q6P5S8; 		26-206
1×GLC; 11×NAG; 2×EDO; 1×HEZ;
Assess
HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibo…
2ny4
 Heteromer
P01730; P19551; Q6P5S8; 		26-206
1×GLC; 13×NAG; 1×HEZ;
Assess
HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibo…
2ny3
 Heteromer
P01730; Q6N030; Q6P5S8; Q993A8; 		26-206
1×GLC; 13×NAG;
Assess
HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b
2nxy
 Heteromer
P01730; Q49DS8; Q6N095; Q6P5S8; 		26-206
13×NAG; 3×HEZ; 1×TRS;
Assess
HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b
2nxz
 Heteromer
P01730; P19551; Q6P5S8; 		26-206
1×GLC; 13×NAG; 3×EDO; 1×HEZ; 1×IPA;
Assess
HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1rzj
 Heteromer
P01730; P04578; 		26-206
2×NAG; 12×NAG; 1×IPA;
Assess
HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1g9m
 Heteromer
P01730; P04578; 		26-206
2×NAG; 12×NAG; 1×IPA;
Assess
HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD…
2ny0
 Heteromer
P01730; P19551; Q6P5S8; 		26-206
12×NAG; 1×HEZ;
Assess
HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
1gc1
 Heteromer
P01730; P04578; 		26-206
4×NAG; 7×NAG;
Assess
HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Com…
2ny5
 Heteromer
P01730; P19551; Q6P5S8; 		26-206
1×GLC; 9×NAG;
Assess
HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431…
2ny6
 Heteromer
P01730; Q6N030; Q6P5S8; Q8Q7Z9; 		26-206
1×GLC; 8×NAG;
Assess
HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1g9n
 Heteromer
P01730; P35961; 		26-206
14×NAG;
Assess
HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1rzk
 Heteromer
P01730; P35961; 		26-206
14×NAG;
Assess
Crystal structure of fully glycosylated HIV-1 gp120 core bound to CD4 and 17b Fab
4rqs
 Heteromer
P01730; P35961; 		26-206
1×NAG; 4×NAG; 3×NAG; 1×NAG;
Assess
Model of gp120, including variable regions, in complex with CD4 and 17b
3j70
 Heteromer
P01730; P04578; 		26-206
Assess
negative stain EM of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195
5a7x
 Heteromer
P01730; P35961; 		26-206
45×NAG;
Assess
cryo-ET subtomogram averaging of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195
5a8h
 Heteromer
P01730; P35961; 		26-206
45×NAG;
Assess
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody
3o2d
 Heteromer
P01730; 		26-203
Assess
Crystal structure of CD4 mutant bound to HLA-DR1
3s4s
 Heteromer
P01730; P01903; P01911; P03437; 		26-203
1×GOL;
Assess
Structure of tyrosine-sulfated 412d antibody complexed with HIV-1 YU2 gp120 and CD4
2qad
 Heteromer
A4F255; P01730; P35961; 		26-203
16×NAG; 2×MLA; 4×EDO;
Assess
Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120
4r4h
 Heteromer
P01730; Q73372; 		26-203
8×NAG;
Assess
CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLEC…
1jl4
 Heteromer
P01730; P01910; P02789; P06343; 		26-203
Assess
Crystal structure of CD4 mutant bound to HLA-DR1
3s5l
 Heteromer
P01730; P01903; P01911; P03437; 		27-203
5×GOL;
Assess
structure of gp120/CD4 with a non-canonical surface
6l1y
 Heteromer
G4XFJ5; P01730; 		26-202
8×NAG; 1×EPE;
Assess
Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/…
4h8w
 Heteromer
P01730; Q0ED31; 		26-201
10×NAG; 3×MRD; 1×GOL;
Assess
Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2
4p9h
 Heteromer
P01730; Q0ED31; 		27-202
2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×EPE; 2×BEN; 3×NAG;
Assess
anti-HIV-1 gp120-sCD4 complex antibody CG10 Fab in complex with B41-sCD4
8d5c
 Heteromer
B3UES2; P01730; 		26-201
Assess
Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding var…
5vn3
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-201
12×NAG; 12×NAG; 3×NAG; 6×NAG; 24×NAG;
Assess
Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly n…
7txd
 Heteromer
P01730; Q2N0S6; 		26-201
2×NAG; 8×NAG; 11×NAG; 1×NAG; 30×NAG;
Assess
Structure of HIV-1 BG505 SOSIP-HT1 in complex with one CD4 molecule
8fyi
 Heteromer
P01730; Q2N0S5; 		26-201
5×NAG; 2×NAG; 1×NAG; 1×NAG; 35×NAG;
Assess
Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I)
8fyj
 Heteromer
P01730; Q2N0S5; Q2N0S6; 		26-201
4×NAG; 4×NAG; 1×NAG; 7×NAG;
Assess
Structural basis of coreceptor recognition by HIV-1 envelope spike
6meo
 Heteromer
P01730; P51681; Q70145; 		26-201
6×NAG; 2×NAG; 1×NAG; 7×NAG; 1×BMA; 1×A2G;
Assess
Crystal Structure of PGT 135 Fab in Complex with gp120 Core Protein from HIV-1 Strain JR-FL Bound t…
4jm2
 Heteromer
P01730; Q75760; 		26-200
1×NAG; 1×NAG; 1×NAG; 1×PG4; 6×NAG;
Assess
Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4
4r2g
 Heteromer
P01730; P0DOX5; P0DOY3; P20871; 		26-200
1×NAG; 8×NAG; 1×CL; 1×GOL;
Assess
Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) compl…
2b4c
 Heteromer
P01730; Q75760; 		26-200
1×NAG; 3×NAG; 5×SO4; 3×XYL;
Assess
Crystal structure of clade C gp120 in complex with sCD4 and 21c Fab
3lqa
 Heteromer
P01730; Q1PHM6; 		27-201
4×NAG;
Assess
Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 3…
3jcc
 Heteromer
A0A3B6UDT5; P01730; 		26-200
Assess
Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 3…
3jcb
 Heteromer
A0A3B6UDT5; P01730; 		26-200
Assess
Envelope glycoprotein gp120 core from HIV type 2 bound to the first two domains of human soluble CD…
5cay
 Heteromer
P01730; P20872; 		27-199
1×NAG; 1×NAG; 6×NAG;
Assess
Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex
5thr
 Heteromer
P01730; Q2N0S6; 		26-123
3×NAG; 6×NAG;
Assess
Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM
6opp
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-122
16×NAG; 10×NAG; 2×NAG; 4×NAG; 1×NAG; 3×LMT; 24×NAG;
Assess
CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG
6opq
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-122
24×NAG; 3×NAG; 9×NAG;
Assess
Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM
6opo
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-122
24×NAG; 3×NAG; 3×NAG; 18×NAG; 3×LMT;
Assess
BG505 SOSIP in complex with sCD4, 17b, 8ANC195
6cm3
 Heteromer
P01730; Q2N0S5; Q2N0S7; 		26-122
6×NAG; 3×NAG; 6×NAG; 18×NAG;
Assess
Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex w…
6u0l
 Heteromer
P01730; Q2N0S6; 		26-122
4×NAG; 2×NAG; 1×NAG; 21×NAG;
Assess
Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex …
6u0n
 Heteromer
P01730; Q2N0S6; 		26-122
2×NAG; 3×NAG; 24×NAG;
Assess
B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the b…
6edu
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-122
15×NAG; 6×NAG; 3×NAG; 3×NAG; 27×NAG;
Assess
Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52
6x5b
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-121
3×NAG; 3×NAG; 27×NAG; 3×UOV;
Assess
Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52
6x5c
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-121
3×NAG; 1×NAG; 23×NAG; 3×UOV;
Assess
CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35
6opn
 Heteromer
B3UES2; B3UEZ6; P01730; 		26-120
3×NAG; 3×NAG; 27×NAG; 3×N07;
Assess
Solution structure of T-cell surface glycoprotein CD4 and Proto-oncogene tyrosine-protein kinase LC…
1q68
 Heteromer
P01730; P06239; 		421-458
1×ZN;
Assess
HIV-1 Nef in complex with the CD4 cytoplasmic domain and the AP2 clathrin adaptor complex
6uri
 Heteromer
P01730; P03406; P18484; P53680; P63010; Q96CW1; 		431-444
Assess
CD4 endocytosis motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kina…
3b71
 Heteromer
P01730; Q05397; 		431-441
Assess
AP2 CLATHRIN ADAPTOR CORE with Dileucine peptide RM(phosphoS)QIKRLLSE
2jkr
 Heteromer
P01730; P17427; P62743; P63010; P84092; 		432-440
14×SO4;
Assess
AP2 CLATHRIN ADAPTOR CORE with CD4 Dileucine peptide RM(phosphoS) EIKRLLSE Q to E mutant
2jkt
 Heteromer
P01730; P17427; P62743; P63010; P84092; 		432-440
15×SO4;
Assess
AP2 clathrin adaptor mu2T156-phosphorylated core with two cargo peptides in open+ conformation
6qh7
 Heteromer
P01730; P18484; P62744; P63010; P84092; 		432-440
Assess
AP2 clathrin adaptor core with two cargo peptides in open+ conformation
6qh6
 Heteromer
P01730; P18484; P62743; P63010; P84092; Q3ZC13; 		432-440
Assess
STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES
1cdi
homo-2-mer25-203
Assess
REFINEMENT AND ANALYSIS OF THE FIRST TWO DOMAINS OF HUMAN CD4
3cd4
homo-2-mer26-203
Assess
STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES
1cdh
homo-2-mer26-203
Assess
STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TETRAGONAL CRYSTAL FORM
1wio
monomer26-388
Assess
STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM
1wip
monomer26-388
Assess
STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TRIGONAL CRYSTAL FORM
1wiq
monomer26-388
Assess
STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH GLY 47 REPLACED BY SER
1cdy
monomer26-203
Assess
STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4
1cdj
monomer26-203
Assess
STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH PHE 43 REPLACED BY VAL
1cdu
monomer26-203
Assess
NMR structure of the transmembrane and cytoplasmic domains of human CD4
2klu
monomer397-458
Assess
SOLUTION STRUCTURE OF THE HUMAN CD4 (403-419) RECEPTOR PEPTIDE, NMR, 32 STRUCTURES
1wbr
monomer428-444
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7t0r.1.Cmonomer0.7526-386
100.00
Assess
2klu.1.Amonomer0.69398-458
91.80
Assess
7db6.1.Dmonomer0.5527-201
20.22
Assess
6oel.1.Emonomer0.5426-203
17.34
Assess